Orthofix director granted 14,965 deferred stock units

Orthofix Medical Inc. director Charles R. Kummeth reported receiving an award of 14,965 deferred stock units of common stock as a compensation grant.

Rhea-AI Filing Summary

Orthofix Medical Inc. director Charles R. Kummeth reported receiving an award of 14,965 deferred stock units of common stock as a compensation grant. The units were granted at $0.00 per share, indicating they are not an open-market purchase but an equity award.

The deferred stock units vest in full on the first anniversary of the grant date, subject to his continued service. Each vested unit represents the right to receive one share of Orthofix common stock, which will be delivered within 45 days after his termination of service. Following this award, Kummeth holds 76,305 shares in total, including 42,343 previously reported deferred stock units and 2,103 shares acquired under Orthofix’s Stock Purchase Plan.

Insider Trade Summary

Grant/Award: 14,965 shares

Grant/Award 1 txn

Insider Kummeth Charles R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,965	$0.00	$0.00

Holdings After Transaction: Common Stock — 76,305 shares (Direct)

Footnotes (2)

1. F1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
2. F2. Includes 42,343 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

Key Figures

Deferred stock units granted: 14,965 units Grant price per unit: $0.00 per share Total shares after transaction: 76,305 shares +4 more

7 metrics

Deferred stock units granted 14,965 units Equity award to director on 2026-06-10

Grant price per unit $0.00 per share Compensation-related award, not market purchase

Total shares after transaction 76,305 shares Holdings following Form 4 transaction

Previously reported deferred stock units 42,343 units Included in post-transaction total holdings

Shares from Stock Purchase Plan 2,103 shares Acquired under Orthofix’s SPP on 10/31/2025 and 4/30/2026

Vesting schedule 1 year from grant date Deferred stock units vest on first anniversary

Settlement timing Within 45 days Settlement into stock after termination of service

Key Terms

deferred stock units, Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)

4 terms

deferred stock units financial

"Represents an award of deferred stock units that vest in full on the first anniversary..."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Stock Purchase Plan financial

"Includes 42,343 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan..."

A stock purchase plan is a company-run program that lets employees or qualifying investors buy the company’s shares regularly, often through paycheck deductions and sometimes at a discounted price or with matching contributions. It matters because it encourages ownership—like a workplace discount for buying company products—aligning interests between holders and managers, while affecting share supply and potential value for outside investors.

Rule 16b-3(b)(5) regulatory

"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)..."

Section 16(b) regulatory

"share acquisitions under the plan are exempt from Section 16(b)."

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Orthofix Medical (OFIX) director Charles R. Kummeth report in this Form 4?

Charles R. Kummeth reported receiving an equity award of 14,965 deferred stock units of Orthofix Medical common stock. This is a compensation-related grant rather than an open-market share purchase or sale.

How many Orthofix (OFIX) deferred stock units were granted to Charles R. Kummeth?

He was granted 14,965 deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Orthofix common stock, subject to vesting and later settlement terms described in the award.

When do Charles R. Kummeth’s new Orthofix (OFIX) deferred stock units vest and settle?

The 14,965 deferred stock units vest in full on the first anniversary of the grant date, if he continues serving. Vested units will convert into common stock within 45 days after his termination of service with Orthofix.

How many Orthofix (OFIX) shares does Charles R. Kummeth hold after this transaction?

After the award, he holds a total of 76,305 Orthofix shares. This figure includes 42,343 previously reported deferred stock units and 2,103 shares acquired under Orthofix’s Stock Purchase Plan.

Are Charles R. Kummeth’s Orthofix (OFIX) share acquisitions under the Stock Purchase Plan subject to Section 16(b)?

The filing states Orthofix’s Stock Purchase Plan is a “Stock Purchase Plan” under Rule 16b-3(b)(5). Share acquisitions under this plan are described as exempt from Section 16(b) short-swing profit rules for insiders.

Is Charles R. Kummeth’s Orthofix (OFIX) Form 4 transaction a market purchase or sale?

No. The Form 4 describes a grant of 14,965 deferred stock units at a price of $0.00 per share. This indicates a compensation-related award, not an open-market buy or sell transaction in Orthofix shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 06:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kummeth Charles R.

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		14,965(1)	A	$0	76,305(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

2. Includes 42,343 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

	/s/ J. Andres Cedron, attorney-in-fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)